I

n an intriguing case, a federal court jury awarded nearly $8 million to the former top lawyer at a small life sciences company, who claimed he was fired after reporting that bribes were paid in China.

The verdict, which was handed down on Monday, capped an unusual episode that was being closely watched by lawyers and companies nationwide, not just the pharmaceutical industry, because of an unusual twist — the former general counsel was also the whistleblower. It also arrives as a growing number of drug makers have been fined for paying bribes in foreign countries.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.